Ecolab is no longer just a cleaning-chemicals compounder. The completion of the CoolIT Systems acquisition on July 2, 2026 closed the financing on a decisive pivot: a $4.75 billion bet that turns the Global Water segment into a hyperscaler-aligned infrastructure supplier at exactly the moment artificial-intelligence training buildouts are straining conventional air cooling. The transaction, funded with $5.0 billion of senior notes priced May 29, 2026 across 3-year, 5-year, 7-year, and 10-year tranches at coupons of 4.60 percent to 5.35 percent, is the largest single move in company history and arrives just five months after the $1.6 billion December 2025 close on Ovivo Electronics. Together, those two deals move the company from a defensive hygiene and water-treatment operator into the secular data-center capex tailwind while preserving the 53 percent United States revenue mix and the four-segment reporting structure that anchored the underlying Q2 2026 print of $4,415.4 million in net sales, up 9.7 percent year over year, and $757.9 million of operating income, up 6.7 percent.
The thesis rests on three variables worth tracking. The first is Global Life Sciences, where Q2 2026 fixed-currency sales grew 15.4 percent to $221.0 million with organic operating income margins expanding 5.5 percentage points to 26.5 percent on what management called a spike in bioprocessing; any sustained double-digit growth at that margin profile materially re-rates the four-segment sum-of-the-parts. The second is CoolIT revenue contribution and the timing of the integration into Global Water; the deal closed July 2, 2026, so Q3 2026 will be the first quarter with CoolIT inside reported results, and any commentary on revenue per megawatt of liquid cooling capacity will define the multiple expansion path. The third is the One Ecolab cost program, which has now delivered $180 million of cumulative savings against a $325 million annualized run-rate target by 2027, with $250.2 million of cumulative restructuring charges and $65.0 million of cumulative special charges already booked, leaving the remaining $78 million of restructuring and $32 million of special charges as a known pull-forward into 2026 and 2027.
What confirms the thesis is a Q3 2026 print in which Global Water fixed-currency sales growth re-accelerates above 10 percent with CoolIT contributing incremental revenue, Global Life Sciences maintains the high-teens organic growth trajectory, and the One Ecolab program steps from $180 million cumulative savings toward the $325 million annualized target. What breaks the thesis is a CoolIT integration that produces margin compression in Global Water, a second-half data-center capex pause that hits the High-Tech vertical, or a renewed commodity-cost surge that overwhelms the energy surcharge Ecolab announced and started implementing in Q2 2026.